Rentokil Initial plc (LON:RTO – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 377.97 and traded as high as GBX 434.20. Rentokil Initial shares last traded at GBX 433.20, with a volume of 312,918,719 shares.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on RTO shares. Berenberg Bank upped their price objective on Rentokil Initial from GBX 284 to GBX 300 and gave the company a “sell” rating in a report on Monday, November 3rd. UBS Group reaffirmed a “neutral” rating and issued a GBX 380 price target on shares of Rentokil Initial in a research note on Friday, October 17th. Finally, Citigroup raised their price objective on Rentokil Initial from GBX 470 to GBX 500 and gave the stock a “buy” rating in a research report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of GBX 414.17.
Read Our Latest Report on Rentokil Initial
Rentokil Initial Price Performance
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
- Five stocks we like better than Rentokil Initial
- Investing In Preferred Stock vs. Common Stock
- Why Amazon Could Be a $300 Stock Within Weeks
- Pros And Cons Of Monthly Dividend Stocks
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- Industrial Products Stocks Investing
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
